Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
SHR4640 dose1
DRUG
2 trials
Sponsors
Jiangsu HengRui Medicine Co., Ltd.
Conditions
Gout
Hyperuricemia
Phase 1
The Drug-Drug Interaction of SHR4640 and Febuxostat in Patients With Hyperuricemia
NCT04157959
Jiangsu HengRui Medicine Co., Ltd.
Hyperuricemia
Start: 2019-10-14
End: 2020-06-30
Target: 28
Updated: 2019-11-08
Phase 3
A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout
Completed
NCT04052932
Jiangsu HengRui Medicine Co., Ltd.
Gout
Start: 2019-07-16
End: 2021-07-14
Updated: 2022-06-13